Navigation Links
Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis

ing research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2006, sales by the Pharmaceuticals Division totaled 33.3 billion Swiss franc ($26.6 billion US), and the Diagnostics Division posted sales of 8.7 billion Swiss franc ($6.96 billion US). Roche employs roughly 75,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information, about the Roche Group is available on the Internet at http://www.roche.com.

All trademarks used or mentioned in this release are protected by law.

This news release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and forward-looking information within the meaning of applicable securities laws in Canada (collectively, "forward-looking statements"). The words "anticipates", "believes", "budgets", "could", "estimates", "expects", "forecasts", "intends", "may", "might", "plans", "projects", "schedule", "should", "will", "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this news release include, but are not limited to, statements about: our strategy, future operations, clinical trials, prospects and plans of management; the effects of CellCept on patients; our expectations with respect to our existing collaboration agreement with Roche for the dev
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... Powers Lake, Wisconsin , announce ... distribution and co-marketing agreement allowing ScriptPro to bring ... the United States . ScriptPro ... and workflow systems to retail and ambulatory pharmacies. ...
(Date:7/25/2014)... , July 25, 2014 Cardinal Health ... community pharmacies as winners of its prestigious Independent Pharmacy ... Conference , one of the nation,s largest gatherings of ... winners – family-owned pharmacies from Ohio ... Texas – were selected for implementing exceptionally ...
(Date:7/25/2014)... , July 25, 2014 Research and ... "Global Ophthalmic Diagnostic Devices Market 2014-2018" report to ... About Ophthalmic Diagnostic Device ... to identify a defect or deficiency in the human ... ophthalmic disorders such as presbyopia, cataracts, glaucoma, retinal disorders, ...
Breaking Medicine Technology:ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... 25 QBC Diagnostics was awarded one of the largest ... agreed to install QBC STAR hematology analyzers on surface ships ... a 9-parameter complete blood count through its patented dry hematology ... this technology, as well as the unit,s small footprint and ...
... a leading provider of healthcare software solutions specializing in ... today that the company has once again been ranked ... Inc. magazine. This marks Edifecs, second consecutive ... jump from #2301 to #1983. (Logo: ...
Cached Medicine Technology:Edifecs Rises on 2010 Inc.5000 List of Fastest-Growing Private Companies in the U.S. 2
(Date:7/25/2014)... As reported by Wood TV 8 in ... Michigan has seen a nearly 500-person increase in heroin related ... was 271 between 1999 and 2002, the toll increased to ... like other states, drug users in Michigan have turned to ... He compared the price of both substances, noting that an ...
(Date:7/25/2014)... TX (PRWEB) July 25, 2014 The ... Family Fun Fest on Sunday, July 27 at Discovery ... franchises include Memorial, Copperfield, Katy, Pearland, Friendswood, Spring, The ... in The Heights. , “We’re thrilled to be ... year,” said Heather Belcher who owns the Sugarland-Missouri City ...
(Date:7/25/2014)... Art of Facial Surgery has recently stepped up to ... are looking for minor touch-ups to make them more photogenic. ... Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) and ... showed a surprising increase between 2012 and 2013. The ... increased by 7 percent and eyelid surgery increased by 6 ...
(Date:7/25/2014)... Washington, NY (PRWEB) July 25, 2014 ... protecting the rights of consumers comments on a recent ... widow of a smoker $23.6 billion in punitive damages. ... manufactures Kool brand cigarettes. The case is Cynthia Robinson ... 2008 in the Florida First Circuit Court, Escambia County, ...
(Date:7/25/2014)... AZ (PRWEB) July 25, 2014 Hastings ... offering discount attorney’s fees with regard to personal ... Hastings provide a wide range of legal services for ... the negligence of another individual or corporation. Free initial ... determining the validity of a potential personal injury ...
Breaking Medicine News(10 mins):Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3
... is a new wonder slimming FDA approved drug which can actually ... all while you are slimming. This wonder slimming drug is XENICAL. ... a meal // to pass through the gut undigested. Your body ... as a source of energy. This will therfore help you to ...
... become available. As people age, their bones become weak and ... is hormone replacement therapy. But this can increase the risk ... of Arkansas in Little Rock, Stavros Manolagas and Starvroula Kousteni ... cells alive, at the same time not increase the risk ...
... technique for prostate cancers has been found out by researchers. ... In the traditional exam for prostate cancer, the doctor takes ... Ohio State University, researchers said that it is better to ... this the extended sector biopsy. They took 12 ...
... people who commit sucide have heavier brains than most people. ... men and 1300g in women, but can drop in weight ... ,Emad Salid from Liverpool University and George Tadros from the ... on this unusual weight increase in sucide victims. ,A ...
... the FDA for the acute treatment of migraine with ... to a class of drugs known as selective serotonin ... receptor agonist.// ,This drug targets serotonin receptors and ... blood vessels surrounding the brain. ,Nausea, sleepiness, numbness, ...
... Dr.Bell from Duke University NC. ,Years ago, anesthesia had ... and obesity both make it difficult to breathe under general ... conditions are combined.// ,Bell and colleagues studied more than ... a measurement of body fat calculated using a formula that ...
Cached Medicine News:
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid Yeast Plus, a microbial identification system....
IDS Rapid NH, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Medicine Products: